Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Agnosia × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 45 Neoplasms 36 Colorectal Neoplasms 23 Lung Neoplasms 22 Prostatic Neoplasms 15 Uterine Cervical Neoplasms 13 Motor Activity 12 Colonic Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Rectal Neoplasms 8 Melanoma 8 Anxiety Disorders 8 Urinary Bladder Neoplasms 7 Obesity 7 Lymphoma 7 Hematologic Neoplasms 7 Vulvar Neoplasms 6 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Depression 6 Breast Carcinoma In Situ 6 Pain 5 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Stomach Neoplasms 4 Sarcoma 4 Papillomavirus Infections 4 Leukemia, Myeloid, Acute 4 Fatigue 4

Interventions

Bupivacaine 9 Ketamine 8 Analgesics, Opioid 8 Dexmedetomidine 7 Ropivacaine 6 Fentanyl 6 Anesthesia, General 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Acupuncture Therapy 5 Tramadol 4 Surveys and Questionnaires 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Tea 2 Oxycodone 2 Magnesium Sulfate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07332377 2026-03-18

PsyMINT

Virginia Commonwealth University

Phase NA Recruiting

Agnosia, Alzheimer Disease, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡